Biosite Hints Inverness Bid Is 'Superior' to Beckman's; Firms Plan Talks

Apr 10, 2007

NEW YORK (GenomeWeb News) — Biosite today said it will start discussions with Inverness Medical Innovations about Inverness’s offer to buy the company for $90 a share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

A Butterfly's Wings

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

Best Options

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

This Week in PNAS

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Main menu